Biomerica (BMRA) Other financing activities (2021 - 2026)

Biomerica has disclosed Other financing activities across 6 years of filings, most recently posting $25000.0 for Q1 2026.

• Other financing activities for Q1 2026 came in at $25000.0, down 79.17% year-over-year; the trailing twelve-month figure through Feb 2026 was -$52000.0 (down 105.18% YoY), and the FY2025 annual result was $44000.0, down 45.68% from the prior year.
• Other financing activities came in at $25000.0 for Q1 2026 at Biomerica, up from -$126000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $652000.0 in Q2 2023 to a low of -$126000.0 in Q4 2025.
• The 5-year median for Other financing activities is $25000.0 (2026), against an average of $78684.0.
• Across the five-year window, Other financing activities surged 152951.64% in 2023 and slumped 181.29% in 2025, its largest moves.
• Biomerica's Other financing activities stood at $5000.0 in 2022, then soared by 12940.0% to $652000.0 in 2023, then slumped by 76.23% to $155000.0 in 2024, then plunged by 181.29% to -$126000.0 in 2025, then jumped by 119.84% to $25000.0 in 2026.
• The last three Other financing activities figures came in at $25000.0 (Q1 2026), -$126000.0 (Q4 2025), and $133000.0 (Q3 2025), per Business Quant data.